Literature DB >> 19115105

HER2 as marker for the detection of circulating tumor cells.

Volkmar Müller1, Klaus Pantel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19115105     DOI： 10.1007/s10549-008-0276-y

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  5 in total

1.  Analysing the mutational status of PIK3CA in circulating tumor cells from metastatic breast cancer patients.

Authors:  Helen Schneck; Christina Blassl; Franziska Meier-Stiegen; Rui Pedro Neves; Wolfgang Janni; Tanja Fehm; Hans Neubauer
Journal:  Mol Oncol       Date:  2013-07-13       Impact factor: 6.603

2.  A multimarker QPCR-based platform for the detection of circulating tumour cells in patients with early-stage breast cancer.

Authors:  T J Molloy; L A Devriese; H H Helgason; A J Bosma; M Hauptmann; E E Voest; J H M Schellens; L J van't Veer
Journal:  Br J Cancer       Date:  2011-05-17       Impact factor: 7.640

3.  Gene expression profile of circulating tumor cells in breast cancer by RT-qPCR.

Authors:  Areti Strati; Athina Markou; Cleo Parisi; Eleni Politaki; Dimitris Mavroudis; Vasilis Georgoulias; Evi Lianidou
Journal:  BMC Cancer       Date:  2011-10-04       Impact factor: 4.430

4.  EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.

Authors:  Helen Schneck; Berthold Gierke; Frauke Uppenkamp; Bianca Behrens; Dieter Niederacher; Nikolas H Stoecklein; Markus F Templin; Michael Pawlak; Tanja Fehm; Hans Neubauer
Journal:  PLoS One       Date:  2015-12-22       Impact factor: 3.240

5.  Molecular detection of peripheral blood breast cancer mRNA transcripts as a surrogate biomarker for circulating tumor cells.

Authors:  Adriana Lasa; Arnal Garcia; Carmen Alonso; Pilar Millet; Mónica Cornet; Teresa Ramón y Cajal; Montserrat Baiget; Agusti Barnadas
Journal:  PLoS One       Date:  2013-09-18       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.